Hostname: page-component-7479d7b7d-8zxtt Total loading time: 0 Render date: 2024-07-12T08:55:28.676Z Has data issue: false hasContentIssue false
  • English
  • Français

HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL-EASTERN AND SOUTH EUROPE COUNTRIES: BOSNIA AND HERZEGOVINA

Published online by Cambridge University Press:  24 April 2017

Vladimir Guzvic ,
Tarik Catic  and
Marina Kostic
Vladimir Guzvic
Affiliation:
Health Insurance Fund of Republic of Srpskaguzvic80@yahoo.com
Tarik Catic
Affiliation:
ISPOR BiH
Marina Kostic
Affiliation:
University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Pharmacology and toxicology
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: The aim of this study was to describe the healthcare system and health financing in Bosnia and Herzegovina and recent trends in health technology assessment (HTA) placement in the system.

Methods: A short review of PubMed published literature has been conducted using key words related to reimbursement, HTA, and health policy. We also revised legislation in Bosnia and Herzegovina published in Official Gazettes related to healthcare financing and organization.

Results: A deecentralized system in Bosnia and Herzegovina led to high differences in health policy. HTA has been recognized in legislation in Bosnia and Herzegovina, but it still has not been introduced in practice in full capacity. A small number of publications are found in PubMed treating these issues, but generally the problem of introduction of HTA in Bosnia and Herzegovina is lack of experts, as well as the political environment and education in this field.

Conclusions: HTA in the Federation of Bosnia and Herzegovina and the Republic of Srpska has a short history because of a huge political impact in the decision-making process, decentralized system, and multiple decision makers in these regions. Challenges remain in assessments, in development of more transparent approaches in different areas of the health system in these regions, and in consistent application of appropriate standards especially in education of professionals who will provide establishment of HTA in the health system of The Federation of Bosnia and Herzegovina and the Republic of Srpska.

Keywords

Health technology assessmentHealth policyHealth financing
Type
Theme Submissions
Information
International Journal of Technology Assessment in Health Care , Volume 33 , Issue 3: Theme: HTA in Central-Eastern-Southern Europe , 2017 , pp. 390 - 395
Copyright
Copyright © Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. US Department of State. http://www.state.gov/p/eur/rls/or/dayton/52577.htm (accessed November 7, 2015).Google Scholar
2. Ministry of Civil Affairs of Bosnia and Herzegovina. http://www.mcp.gov.ba (accessed November 7, 2015).Google Scholar
3. Federal Ministry of Health. http://www.fmoh.gov.ba/ (accessed November 7, 2015).Google Scholar
4. Federal Health Insurance Fund. http://www.fedzzo.com.ba/bs/clanak/fond-solidarnosti/38 (accessed November 8, 2015)Google Scholar
5. Decision on medicines financed by Solidarity fund of Federation of Bosnia and Herzegovina. Official gazette of Federation of Bosnia and Herzegovina 89/13 (in Bosnian).Google Scholar
6. Health Insurance Law in Federation of Bosnia and Herzegovina. Official gazette of Federation of Bosnia and Herzegovina 30/97, 7/02, 70/08 and 48/11 (in Bosnian).Google Scholar
7. Cain, J, Durán, A, Fortis, A, Jakubowski, E. Heath care systems in transition: Bosnia and Herzegovina. Copenhagen: European Observatory on Health Care Systems. 2002.Google Scholar
8. Decision on essential medicines list in Federation of Bosnia and Herzegovina. Official gazette of Federation of Bosnia and Herzegovina 74/14 (in Bosnian).Google Scholar
9. Ministry of Health of Republic of Srpska. http://www.vladars.net/sr-SP-Cyrl/Vlada/Ministarstva/MZSZ/Pages/default.aspx (accessed November 7, 2015).Google Scholar
10. Health Insurance Fund of Republic of Srpska. https://www.zdravstvo-srpske.org (accessed November 7, 2015).Google Scholar
11. Decisions on medicines on A and B list. Official gazette of Republic of Srpska 86/15 (in Bosnian).Google Scholar
12. Decision on medicines on Ambulatory list. Official gazette of Republic of Srpska 78/15 (in Bosnian).Google Scholar
13. Decision on medicines on Hospital list. Official Gazette of Republic of Srpska 65/15 (in Bosnian).Google Scholar
14. Decision of medicines on Cytotoxic and biologics list. Official Gazette of Republic of Srpska 74/15 (in Bosnian).Google Scholar
15. Health care law of Federation of Bosnia and Herzegovina. Official gazette of Federation of Bosnia and Herzegovina 46/10 (in Bosnian).Google Scholar
16. ISPOR Bosnia and Herzegovina Regional Chapter. http://www.farmakoekonomika.ba/ba/index.php?option=com_content&view=article&id=50&Itemid=62&lang=hr (accessed November 10, 2015).Google Scholar
17. Čatić, T, Begović, B. Overview of HTA Process and implementation among health stakeholders in Bosnia and Herzegovina – Survey based research. Value Health. 2011;14:A356.Google Scholar
18. Mahmić-Kaknjo, M, Marušić, A. Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: Role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports. Eur J Clin Pharmacol. 2015;71:825-833 Google Scholar
19. Čatić, T, Martinović, I, Begović, B. The role of pharmacoeconomics in medicines reimbursement decision-making in Bosnia and Herzegovina. Folia Med. 2012;47 (Suppl 1):P50.Google Scholar
20. Danko, D, Petrova, G. Health technology assessment in the Balkans: Opportunities for a balanced drug assessment system. Biotechnol Equip. 2014;28:1181-1189.Google Scholar
21. Čatić, T, Skrbo, S. Pharmacoeconomic education for pharmacy students in Bosnia and Herzegovina. Mater Sociomed. 2013;25:282-285.Google Scholar
22. Čatić, T. Pharmacoeconomic education for health care students in Bosnia and Herzegovina. Value Health. 2013;16:A479.Google Scholar
23. Agency for quality and accreditation in health and social care. http://aaz.hr/procjena-zdravstvenih-tehnologija (Accessed July 6, 2016).Google Scholar
24. Novo, A, Hasanović, E. Health technology assessment and Bosnia and Herzegovina. Mater Sociomed. 2006;18:76-78.Google Scholar
25. Zechmeister, I, Schumacher, I. The impact of health technology assessment reports on decision making in Austria. Int J Technol Assess Health Care. 2012;28:77-84 Google Scholar
26. Dixon, S, Coleman, P, Nicholl, J, Brennan, A, Touch, S. Evaluation of the impact of a technology appraisal process in England: The South and West Development and Evaluation Committee. J Health Serv Res Policy. 2003;8:18-24.Google Scholar
27. Jonsson, E, Banta, HD, Schersten, T. Health technology assessment and screening in Sweden. Int J Technol Assess Health Care. 2001;17:380-388 Google Scholar